Dec 182017
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, IN – Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel oral live biotherapeutics for disorders associated with the microbiome, today announced the appointment of Sue Mahony, PhD, to its board of directors, increasing the number of directors from seven to eight.… => Read more

Assembly Biosciences adds Dr Sue Mahony to its Board of Directors

From:: Assembly Biosciences adds Dr Sue Mahony to its Board of Directors

Sorry, the comment form is closed at this time.

%d bloggers like this: